The Industrialization of Exceptions: When Compounding Crosses the Line from Patient Care to Patent Theft
In the rapidly evolving landscape of pharmaceutical innovation, a quiet but critical battle is unfolding—one that could redefine the boundaries between patient care and intellectual property rights. At the heart of this conflict lies a complex issue: w…
